Zindrick Thomas 4
4 · GENELUX Corp · Filed Sep 3, 2025
Insider Transaction Report
Form 4
GENELUX CorpGNLX
Zindrick Thomas
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2025-09-01+925,000→ 925,000 totalExercise: $3.33Exp: 2027-09-18→ Common stock (925,000 underlying) - Award
Stock Option (Right to Buy)
2025-09-01+23,568→ 23,568 totalExercise: $3.33Exp: 2030-09-23→ Common stock (23,568 underlying) - Award
Stock Option (Right to Buy)
2025-09-01+250,000→ 250,000 totalExercise: $3.33Exp: 2033-09-10→ Common stock (250,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2025-09-01−925,000→ 0 totalExercise: $6.00Exp: 2027-09-18→ Common stock (925,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2025-09-01−23,568→ 0 totalExercise: $6.00Exp: 2030-09-23→ Common stock (23,568 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2025-09-01−157,372→ 0 totalExercise: $6.00Exp: 2030-03-22→ Common stock (157,372 underlying) - Award
Stock Option (Right to Buy)
2025-09-01+157,372→ 157,372 totalExercise: $3.33Exp: 2030-03-22→ Common stock (157,372 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2025-09-01−250,000→ 0 totalExercise: $22.40Exp: 2033-09-10→ Common stock (250,000 underlying)
Footnotes (3)
- [F1]The shares subject to these options are fully vested.
- [F2]The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options.
- [F3]The shares subject to the option vest as follows: 25% on September 11, 2024, and the remaining shares vest in 36 equal monthly installments thereafter.